Radcliffe Capital Management’s SAB Biotherapeutics Warrant SABSW Stock Holding History

Radcliffe Capital Management’s Portfolio SABSW Stock Details SABSW Fund Activity

Upgrade to unlock

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell
2022 Q3	$27K	Sell
2022 Q2	$81K	Hold
2022 Q1	$562K	Sell
2021 Q4	$632K	Sell
2021 Q3	$1.75M	Sell
2021 Q2	$1.74M	Hold
2021 Q1	$1.72M	Buy